Records containing: Parkinson's Disease
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2010-12-20ClinicalTrials.gov study NCT01262950
-
CLINICAL_TRIALS study record update · 2010-12-15Post-Marketing Clinical Study of REQUIP (Ropinirole Hydrochloride) Tablets in Patients With Parkinson's Disease- Evaluation of Long-Term Efficacy and Safety -
-
CLINICAL_TRIALS study record update · 2010-12-14Biofeedback-based Motor Learning to Ameliorate Freezing of Gait
-
CLINICAL_TRIALS study record update · 2010-11-23Reduction of Falls in the Elderly - Parkinson's Disease
-
CLINICAL_TRIALS study record update · 2010-11-23Sensory Attention Focused Exercise in Parkinson's Disease: A Randomized Double-Crossover Trial.
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2010-11-16Analysis of Dopamine Neuronal Cell Loss Within the Enteric Nervous System in Parkinson's Disease
-
CLINICAL_TRIALS study record update · 2010-11-11Effects of Vitamin Supplementation and Strength Training in Parkinson's Disease
-
CLINICAL_TRIALS study record update · 2010-11-11Ramelteon (ROZEREM) in the Treatment of Sleep Disturbances Associated With Parkinson's Disease
-
CLINICAL_TRIALS study record update · 2010-11-05Integrated Multidisciplinary Care for Parkinson's Disease: a Controlled Trial
-
CLINICAL_TRIALS study record update · 2010-10-18A Survey to Assess the Incidence and Characteristics of Melanoma in Parkinson's Disease Patients
-
CLINICAL_TRIALS study record update · 2010-10-05A Phase I, Single Center, Blinded, Controlled Study Evaluating Safety, Tolerability and Pharmacokinetic Profile of Levodopa Following Repeated Administration of Oral Levodopa/Carbidopa and Continuously Delivered ND0611
-
CLINICAL_TRIALS study record update · 2010-08-24A Phase III, Double-blind, Placebo-controlled Study to Determine the Efficacy and Safety of a Low (50 mg/Day) and High (100 mg/Day) Dose of Safinamide, as add-on Therapy, in Patients With Idiopathic Parkinson's Disease With Motor Fluctuations, Treated With a Stable Dose of Levodopa and Who May be Receiving Concomitant Treatment With Stable Doses of a Dopamine Agonist, and/or an Anticholinergic
-
CLINICAL_TRIALS study record update · 2010-08-13Levodopa Concentration Profile After Repeated Doses of Different Stalevo® Strengths With 3.5 Hours Dosing Frequency; an Open, Randomised, Crossover, Levodopa/Carbidopa Controlled Single Centre Study in Healthy Subjects, Two Parallel Groups
-
CLINICAL_TRIALS study record update · 2010-08-09Glutathione (GSH) In The Treatment of Parkinson's Disease
-
CLINICAL_TRIALS study record update · 2010-07-21A Double-Blind, Prospective, Randomized Comparison of 2 Doses of MitoQ and Placebo for the Treatment of Patients With Parkinson's Disease
-
CLINICAL_TRIALS study record update · 2010-07-21Parkinson's Disease Registry
-
CLINICAL_TRIALS study record update · 2010-06-03Antidepressant Effect of Deep Brain Stimulation (DBS) in Parkinson's Disease (PD) Patients: Relationship of Stimulation Parameters to Improvement in the Clinical Features of Depression in PD Patients.
-
CLINICAL_TRIALS study record update · 2010-05-26Effects of Chocolate on Motor Symptoms of Parkinson's Disease - A Monocenter, Prospective, Observer-blinded Interventional Trial
-
CLINICAL_TRIALS study record update · 2010-05-25A Single Center, Randomized Controlled, Pilot Study Comparing Group Visits Versus Routine Clinical Care for Participants With Parkinson's Disease (PD).
-
CLINICAL_TRIALS study record update · 2010-05-14A Multi-centre, Randomized, Double-blind, Placebo Controlled, Parallel-group, Multiple Oral Dose Titration Study in Patients With Parkinson's Disease to Assess the Efficacy of AFQ056 in Reducing L-dopa Induced Dyskinesias, and the Safety and Tolerability of AFQ056 in Combination With L-dopa
-
CLINICAL_TRIALS study record update · 2010-04-29Influence of Catechol-O-methyltransferase Polymorphism on Entacapone Efficacy in Parkinson's Disease
-
CLINICAL_TRIALS study record update · 2010-04-12Phase 3B, Multicenter, Multinational, Double-Blind, Placebo Controlled, 2-Arm Trial to Evaluate the Effect of the 24-Hour Transdermal Delivery of Rotigotine on the Control of Early Morning Motor Function, Sleep Quality, Nocturnal Symptoms, and Non-Motor Symptoms in Subjects With Idiopathic Parkinson's Disease
-
CLINICAL_TRIALS study record update · 2010-04-02A Multicenter, Multinational, Phase 3b, Open-label Extension Trial to Evaluate the Long-term Effect of the 24-hour Transdermal Delivery of Rotigotine on Motor Function, Sleep Quality, and Nocturnal and Non-motor Symptoms in Subjects With Idiopathic Parkinson's Disease
-
CLINICAL_TRIALS study record update · 2010-03-31Stabilization on, or Change-over to the Non-ergot Dopamine Agonist Piribedil in Patients With Morbus Parkinson - a Post Marketing Surveillance Study in Parkinson Clinic Ambulances and Larger Private Practices.
-
CLINICAL_TRIALS study record update · 2010-03-25Italian Validation of the Revised MDS-Unified Parkinson's Disease Rating Scale